-- Jointown Pharmaceutical (SHA:600998) unit Beijing Jingfeng Pharmaceutical Shandong passed a good manufacturing practices (GMP) compliance inspection by the Shandong Medical Products Administration for its tablet production lines.
The inspection covered Workshop 801, which produces metformin hydrochloride enteric-coated tablets for type 2 diabetes and isosorbide dinitrate tablets for coronary heart disease and angina, according to a Thursday filing with the Shanghai bourse.
Shares of the pharmaceutical company were down 1% in recent trade.